HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 2 filers reported holding HARPOON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $30,632 | -27.9% | 43,144 | -24.4% | 0.00% | – |
Q1 2023 | $42,479 | +32.7% | 57,080 | +71.1% | 0.00% | – |
Q3 2022 | $32,000 | -13.5% | 33,361 | +73.6% | 0.00% | – |
Q2 2022 | $37,000 | -95.8% | 19,212 | -83.6% | 0.00% | -100.0% |
Q4 2021 | $887,000 | -72.4% | 117,442 | -71.1% | 0.00% | -71.4% |
Q3 2021 | $3,211,000 | +556.6% | 406,470 | +1311.4% | 0.01% | +250.0% |
Q3 2020 | $489,000 | +1.5% | 28,800 | -0.8% | 0.00% | 0.0% |
Q2 2020 | $482,000 | +3.4% | 29,022 | -27.9% | 0.00% | -50.0% |
Q1 2020 | $466,000 | -20.3% | 40,232 | +1.7% | 0.00% | +100.0% |
Q4 2019 | $585,000 | – | 39,551 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,156,699 | $2,335,957 | 1.93% |
MPM ASSET MANAGEMENT LLC | 3,131,388 | $2,329,753 | 0.97% |
MPM BioImpact LLC | 3,196,707 | $2,378,350 | 0.62% |
Lion Point Capital, LP | 169,283 | $125,980 | 0.05% |
Artal Group S.A. | 1,000,000 | $744 | 0.04% |
Cormorant Asset Management, LP | 540,600 | $402 | 0.03% |
KENNEDY CAPITAL MANAGEMENT LLC | 529,934 | $394,377 | 0.01% |
Orbimed Advisors | 621,218 | $462,310 | 0.01% |
Tekla Capital Management LLC | 259,910 | $193,425 | 0.01% |
CM WEALTH ADVISORS LLC | 50,354 | $29 | 0.01% |